Table 2.

Patient Characteristics (N = 19)

Data	Results
Gender -No. (%)
Male	10 (53)
Female	9 (47)
Median age -No. (range)	61 (48–77)
Race -No. (%)
White	19 (100)
Ethnicity -No. (%)
Non-hispanic	19 (100)
Disease Status -No. (%)
Locally Advanced	5 (26)
Metastatic	14 (74)
Baseline Median CA 19-9 Level -No. (quartile)	318 (62-9470)
PS (ECOG) -No. (%)
0	3 (16)
1	16 (84)
Number of Patients Receiving Adjuvant Gemcitabine -No. (%)	6 (32)
Number of Previous Lines of Therapy for Advanced Disease -No. (%)
0	15 (79)
1	3 (16)
2	1 (5)

PS: performance status; ECOG: Eastern Cooperative Oncology Group